Elutia Inc. (ELUT) — 8-K Filings

8-K Filings (24)

• 8-K Filing — Nov 6, 2025
• Elutia Inc. Appoints New Chief Medical Officer — Oct 14, 2025 Risk: medium
  Elutia Inc. announced on October 14, 2025, that its Board of Directors appointed Dr. David L. Smith as Chief Medical Officer, effective October 7, 2025. Dr. Smi
• Elutia Inc. Completes Acquisition of Azura Life Sciences — Oct 7, 2025 Risk: medium
  Elutia Inc. announced on October 7, 2025, the completion of its acquisition of Azura Life Sciences, Inc. The transaction, which closed on October 1, 2025, invol
• Elutia Inc. Files 8-K for Material Agreement — Sep 9, 2025 Risk: medium
  Elutia Inc. (formerly Aziyo Biologics, Inc.) filed an 8-K on September 9, 2025, reporting on a material definitive agreement entered into on September 8, 2025.
• Elutia Inc. Enters Loan Agreement — Aug 20, 2025 Risk: medium
  On August 15, 2025, Elutia Inc. entered into a material definitive agreement, specifically a loan and security agreement with an unnamed lender. This agreement
• Elutia Inc. Files 8-K on Financials — Aug 14, 2025 Risk: low
  Elutia Inc. filed an 8-K on August 14, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and e
• Elutia Inc. Files 8-K on Shareholder Votes — Jun 4, 2025 Risk: low
  Elutia Inc. filed an 8-K on June 4, 2025, reporting on matters submitted to a vote of security holders as of May 29, 2025. The company, formerly known as Aziyo
• Elutia Inc. Files 8-K on Agreements and Operations — May 8, 2025 Risk: medium
  Elutia Inc. filed an 8-K on May 8, 2025, reporting on a material definitive agreement, results of operations, and unregistered sales of equity securities. The c
• Elutia Inc. Terminates Material Definitive Agreement — May 6, 2025 Risk: medium
  Elutia Inc. filed an 8-K on May 6, 2025, reporting the termination of a material definitive agreement as of April 30, 2025. The filing also includes Regulation
• Elutia Inc. Relocates Principal Executive Offices — Mar 6, 2025 Risk: low
  On March 6, 2025, Elutia Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 12510 Prosperity Drive, Suite 3
• Elutia Inc. Files 8-K with Material Agreement Details — Feb 4, 2025 Risk: medium
  On February 3, 2025, Elutia Inc. filed an 8-K report detailing a material definitive agreement. The filing also included Regulation FD disclosures and financial
• Elutia Inc. Files 8-K, Formerly Aziyo Biologics — Feb 3, 2025 Risk: low
  On February 3, 2025, Elutia Inc. (formerly Aziyo Biologics, Inc.) filed an 8-K report. The filing indicates a change in the company's name and jurisdiction of i
• Elutia Inc. Files 8-K on Financials — Nov 14, 2024 Risk: medium
  Elutia Inc. (formerly Aziyo Biologics, Inc.) filed an 8-K on November 14, 2024, reporting on its results of operations and financial condition. The filing also
• Elutia Inc. Enters Material Definitive Agreement — Oct 3, 2024 Risk: medium
  Elutia Inc. entered into a material definitive agreement on September 30, 2024, related to a direct financial obligation. The company, formerly known as Aziyo B
• Elutia Inc. Files 8-K on Financials — Aug 7, 2024 Risk: low
  Elutia Inc. filed an 8-K on August 7, 2024, reporting on its results of operations and financial condition. The filing also includes financial statements and ex
• Elutia Inc. Enters Material Definitive Agreement — Jun 18, 2024 Risk: medium
  On June 16, 2024, Elutia Inc. entered into a material definitive agreement. The company, formerly known as Aziyo Biologics, Inc., is incorporated in Delaware an
• Elutia Inc. Files 8-K with Regulatory Updates — Jun 17, 2024 Risk: low
  Elutia Inc. filed an 8-K on June 17, 2024, reporting events that occurred on June 14, 2024. The filing includes information related to Regulation FD Disclosure,
• Elutia Inc. Files 8-K on Shareholder Vote Matters — Jun 7, 2024 Risk: low
  Elutia Inc. filed an 8-K on June 7, 2024, reporting on matters submitted to a vote of security holders as of June 6, 2024. The company, formerly known as Aziyo
• Elutia Inc. Files 8-K on Financials — May 9, 2024 Risk: low
  Elutia Inc. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition. The filing also includes financial statements and exhib
• Elutia Inc. Reports Material Definitive Agreement — Apr 1, 2024 Risk: medium
  Elutia Inc. filed an 8-K on April 1, 2024, reporting a material definitive agreement entered into on March 27, 2024. The filing also includes financial statemen
• Elutia Inc. Files 8-K on Financials — Mar 7, 2024 Risk: low
  Elutia Inc. filed an 8-K on March 7, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits
• ELUTIA INC. Reports Officer Compensation, Director Changes — Feb 2, 2024
  ELUTIA INC. (formerly AZIYO BIOLOGICS, INC.) filed an 8-K on February 2, 2024, reporting an event that occurred on January 31, 2024. This filing indicates a cha
• ELUTIA INC. Enters Material Definitive Agreement on Jan 10 — Jan 12, 2024
  ELUTIA INC. (formerly AZIYO BIOLOGICS, INC.) filed an 8-K on January 12, 2024, reporting an "Entry into a Material Definitive Agreement" on January 10, 2024. Th
• ELUTIA INC. Updates Contact Info in 8-K Filing — Jan 10, 2024
  ELUTIA INC. filed an 8-K on January 10, 2024, to report an "Other Event." This filing primarily updates the company's contact information, specifically changing

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX